Levaquin

Levaquin Lawsuit Funding Bar

Lawsuit funding is NO LONGER AVAILABLE on Levaquin

Levaquin Lawsuit Loans

What is Levaquin?

Levaquin (Levofloxacin) is a fluroquinolone antibiotic used to treat bacterial infections, and is available only by prescription. On July 8, 2008, the FDA ordered the manufacturer to add a Black Box warning to Levaquin. A Black Box warning is the strongest warning available for prescription drugs. The FDA also required that a guidebook be provided to patients warning about the possible side effects.

People that have been prescribed Levaquin have filed lawsuits claiming that it causes ruptured tendons and that the defendants’ warnings about this side effect were inadequate. Defendants Johnson & Johnson, Ortho-McNeil Pharmaceutical, Inc., and Johnson & Johnson Pharmaceutical Research & Development are denying that Levaquin is defective or unreasonably dangerous. Defendants are also denying that they failed to provide adequate warnings.

The antibiotic Levaquin is in a class of antibiotics called fluroquinolone and has been associated with tendinitis and ruptured tendons. This prompted the FDA in July, 2008 to order that the Levaquin drug maker place a black box warning on its Levaquin medicine. A Levaquin lawsuit alleges that Ortho-McNeil Pharmaceutical did not provide adequate warnings to doctors and patients about the possibility of the drug causing such severe Levaquin side effects: the FDA has reported more than 60 percent of fluoroquinolone-related tendon injuries are linked to Levaquin.

Levaquin Linked To Tendon Ruptures

Levaquin (levofloxacin) is a member of a class of drugs known as quinolones, which are prescribed to fight bacterial infections. Recently complaints by users have led the FDA to put a “black box” warning on the drug to increase awareness of its link to tendon ruptures and tendinitis.

The FDA warning states: “Ruptures of the shoulder, hand, Achilles tendon, or other tendons that required surgical repair or resulted in prolonged disability have been reported in patients receiving quinolones, including levofloxacin. Post-marketing surveillance reports indicate that this risk may be increased in patients receiving concomitant corticosteroids, especially the elderly. Levofloxacin should be discontinued if the patient experiences pain, inflammation, or rupture of a tendon. Patients should rest and refrain from exercise until the diagnosis of tendinitis or tendon rupture has been confidently excluded. Tendon rupture can occur during or after therapy with quinolones, including levofloxacin.”

Levaquin Lawsuit Loans: A Risky Proposition at 50/50

Most lawsuit funding companies do not offer cash advances on Levaquin yet because of the serious risks associated with such a funding. This is because so far, only two Levaquin lawsuits of a reported 2,500 pending claims have made their way to court. One was found in favor of the plaintiff while the other was found in favor of Johnson & Johnson. The first lawsuit resulted in a jury awarded $1.8 million to a man who alleged he ruptured both Achilles tendons. In June 2011, however, a jury found in favor of Johnson & Johnson in a Levaquin lawsuit, after determining that the company properly warned about the risks associated with the antibiotic.

The Judicial Panel on Multi-district Litigation determined that centralizing the Levaquin Tendon Rupture cases was appropriate and all federal cases have been ordered transferred to the District of Minnesota.

Lawsuit funding is NO LONGER AVAILABLE on Levaquin